Inside informationEnglish
Amoéba has received marketing authorization in France for its biofungicide AXPERA
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Amoeba
- Filed
- 30/06/2026, 07:30
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 080270_20260630